Meet us at AASLD, booth #1041 to learn how our deep expertise in imaging-based hepatic biomarkers and global operational support help sponsors optimise trial design and accelerate the delivery of MASH treatments to patie...
Press releases
-
ICON acquires MolecularMD
ICON enhances it molecular diagnostic testing services, a key area in oncology research, with it's acquisition of MolecularMD.
-
ICON launches new drug safety reporting solution ensuring compliance through automation
Developed on platform deploying rule-based automation for timely delivery of drug safety information.
-
-
ICON wins Pharma Contract Services Company of the Year at the Pharma Industry Awards 2018
The Pharma Industry Awards recognise and celebrate innovative individuals and companies that demonstrate excellence in the Irish Pharma sector -
ICON enhances Endpoint Adjudication Services
Agreement to use Judi, a comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality
-
ICON launches FIRECREST Financial Disclosure
The solution enables secure, centralised, electronic distribution and response capture of Financial Disclosure information.
-
ICON named by Forbes as one of the best employers in America
Forbes ranking of top employers drawn from a survey of 30,000 US employees in 25 industry sectors
-
ICON announces clinical research partnership with DuPage Medical Group
Additional PMG Research site locations enhances ICON’s site and patient engagement capabilities
-
ICON and AMAG Pharmaceuticals honoured as Clinical Research Team of the Year
The award honoured the achievements of the team for executing a Phase III iron deficiency anaemia trial
-
ICON receives 2018 CRO Phase IV Leadership Award
ICON recognised for specialised real world evidence and late phase services.
